Form 4 for LH Labcorp
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001127602-25-007615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-04 | 2025-02-28 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale+OE | $249.23 | -5,339 | 4,960 | -52% | -$1.33M |
| D | 2025-03-04 | 2025-02-28 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $131.43 | +3,903 | 10.3K | +61% | +$513.0K |
| D | 2025-03-04 | 2025-02-28 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $0.00 | -3,903 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | S | D | 5,339 | $249.23 | 4,960.14 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-28 | M | A | 3,903 | $131.43 | 10,299.14 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Options | 2025-02-28 | M | D | 3,903 | $0.00 | 0 | D | $131.43 · 2020-02-12 to 2029-02-11 | 3,903 Common Stock | (F2) Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. (F3) The options vested in three equal annual installments beginning on the date reflected in this column. |